Comparison of benign and malignant follicular thyroid tumours by comparative genomic hybridization.

por Hemmer, S., Wasenius, V. M., Knuutila, S., Joensuu, H., Franssila, K.
Publicado 1998

Predictive value of c-erbB-2, p53, cathepsin-D and histology of the primary tumour in metastatic breast cancer.

por Niskanen, E., Blomqvist, C., Franssila, K., Hietanen, P., Wasenius, V. M.
Publicado 1997

Do DNA ploidy and S-phase fraction in primary tumour predict the response to chemotherapy in metastatic breast cancer?

por Hietanen, P., Blomqvist, C., Wasenius, V. M., Niskanen, E., Franssila, K., Nordling, S.
Publicado 1995

Cathepsin-D, urokinase plasminogen activator and type-1 plasminogen activator inhibitor in early breast cancer: an immunohistochemical study of prognostic value and relations to te...

por Jahkola, T, Toivonen, T, Smitten, K von, Virtanen, I, Wasenius, V-M, Blomqvist, C
Publicado 1999

Tumour growth rate and DNA flow cytometry parameters as prognostic factors in metastatic melanoma.

por Muhonen, T., Pyrhönen, S., Laasonen, A., Wasenius, V. M., Asko-Seljavaara, S., Franssila, K., Kangas, L.
Publicado 1992

Endothelial Tie growth factor receptor provides antigenic marker for assessment of breast cancer angiogenesis.

por Salvén, P., Joensuu, H., Heikkilä, P., Matikainen, M. T., Wasenius, V. M., Alanko, A., Alitalo, K.
Publicado 1996

A multivariate analysis of tumour biological factors predicting response to cytotoxic treatment in advanced breast cancer.

por Sjöström, J., Krajewski, S., Franssila, K., Niskanen, E., Wasenius, V. M., Nordling, S., Reed, J. C., Blomqvist, C.
Publicado 1998